Actively Recruiting
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Led by University of Colorado, Denver · Updated on 2025-01-28
400
Participants Needed
1
Research Sites
318 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
H
Haemonetics Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well as thrombotic and hemorrhagic post-operative complications. The investigators further hypothesize that there is histologic pathology correlates to pre-operative TEG abnormalities, and that it identifies patients with virulent tumor biology.
CONDITIONS
Official Title
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- New diagnosis of hepatopancreaticobiliary, esophageal, colorectal, or lung adenocarcinoma confirmed by a physician
- Age 18 years or older
You will not qualify if you...
- Under 18 years old
- Prisoners
- Unable to provide informed consent
- Pregnant women
- Undergoing emergent or urgent surgery at time of diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Colorado Denver
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
T
Tracey MacDermott, BA BS CCRC
CONTACT
I
Ivan Rodriguez, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here